LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,665 | +8.4% | 27,783 | +30.4% | 0.02% | +33.3% |
Q2 2023 | $1,536 | +27.3% | 21,310 | +18.0% | 0.01% | -33.3% |
Q4 2022 | $1,207 | -99.8% | 18,063 | +220.2% | 0.02% | +200.0% |
Q3 2022 | $486,000 | +38.5% | 5,642 | +145.3% | 0.01% | +20.0% |
Q1 2021 | $351,000 | -42.7% | 2,300 | -62.7% | 0.01% | -16.7% |
Q4 2020 | $613,000 | +94.0% | 6,165 | +86.1% | 0.01% | 0.0% |
Q3 2020 | $316,000 | -71.0% | 3,312 | -66.0% | 0.01% | -78.6% |
Q2 2020 | $1,091,000 | – | 9,751 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |